New improvements to gene-editing techniques such as CRISPR/Cas9 may hold promise for inactivating the defective gene responsible for developing Huntington's chorea, finds a new study.
from Medindia Health News http://ift.tt/2BR82FT
LATEST HEALTH NEWS
Reviewed by MZ Digital Marketing Agency
on
February 27, 2018
Rating: 5
No comments
Thanks for comment via will connect you within 24 hours.
No comments
Thanks for comment via will connect you within 24 hours.